BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12581154)

  • 1. Simultaneous acceleration of the cell cycle and suppression of apoptosis by splice variant delta-6 of the candidate tumour suppressor LUCA-15/RBM5.
    Mourtada-Maarabouni M; Sutherland LC; Meredith JM; Williams GT
    Genes Cells; 2003 Feb; 8(2):109-19. PubMed ID: 12581154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition.
    Bonnal S; Martínez C; Förch P; Bachi A; Wilm M; Valcárcel J
    Mol Cell; 2008 Oct; 32(1):81-95. PubMed ID: 18851835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBM5/LUCA-15--tumour suppression by control of apoptosis and the cell cycle?
    Mourtada-Maarabouni M; Williams GT
    ScientificWorldJournal; 2002 Jul; 2():1885-90. PubMed ID: 12920317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes.
    Mourtada-Maarabouni M; Keen J; Clark J; Cooper CS; Williams GT
    Exp Cell Res; 2006 Jun; 312(10):1745-52. PubMed ID: 16546166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candidate tumour suppressor LUCA-15 can regulate multiple apoptotic pathways.
    Mourtada-Maarabouni M; Sutherland LC; Williams GT
    Apoptosis; 2002 Oct; 7(5):421-32. PubMed ID: 12207175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals.
    Rintala-Maki ND; Sutherland LC
    Apoptosis; 2004 Jul; 9(4):475-84. PubMed ID: 15192330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LUCA-15 suppresses CD95-mediated apoptosis in Jurkat T cells.
    Sutherland LC; Lerman M; Williams GT; Miller BA
    Oncogene; 2001 May; 20(21):2713-9. PubMed ID: 11420683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterisation of a novel antisense non-coding RNA from the RBM5 gene locus.
    Rintala-Maki ND; Sutherland LC
    Gene; 2009 Sep; 445(1-2):7-16. PubMed ID: 19559772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiapoptotic RBM5/LUCA-15/H37 gene and its role in apoptosis and human cancer: research update.
    Maarabouni MM; Williams GT
    ScientificWorldJournal; 2006 Dec; 6():1705-12. PubMed ID: 17195868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein.
    Shu Y; Rintala-Maki ND; Wall VE; Wang K; Goard CA; Langdon CE; Sutherland LC
    Cell Biochem Funct; 2007; 25(6):643-53. PubMed ID: 16927403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of genomic structures and expression patterns of two closely related flanking genes in a critical lung cancer region at 3p21.3.
    Timmer T; Terpstra P; van den Berg A; Veldhuis PM; Ter Elst A; Voutsinas G; Hulsbeek MM; Draaijers TG; Looman MW; Kok K; Naylor SL; Buys CH
    Eur J Hum Genet; 1999; 7(4):478-86. PubMed ID: 10352938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis.
    Rintala-Maki ND; Abrasonis V; Burd M; Sutherland LC
    Cell Biochem Funct; 2004; 22(5):307-13. PubMed ID: 15338470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis.
    Oh JJ; Razfar A; Delgado I; Reed RA; Malkina A; Boctor B; Slamon DJ
    Cancer Res; 2006 Apr; 66(7):3419-27. PubMed ID: 16585163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulating RNA Binding Motif 5 Gene Expression- A Novel Therapeutic Target for Lung Cancer.
    Prabhu VV; Devaraj N
    J Environ Pathol Toxicol Oncol; 2017; 36(2):99-105. PubMed ID: 29199590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Death by splicing: tumor suppressor RBM5 freezes splice-site pairing.
    Kotlajich MV; Hertel KJ
    Mol Cell; 2008 Oct; 32(2):162-4. PubMed ID: 18951082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis.
    Sutherland LC; Edwards SE; Cable HC; Poirier GG; Miller BA; Cooper CS; Williams GT
    Oncogene; 2000 Aug; 19(33):3774-81. PubMed ID: 10949932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5.
    Fushimi K; Ray P; Kar A; Wang L; Sutherland LC; Wu JY
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15708-13. PubMed ID: 18840686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours.
    Wang K; Ubriaco G; Sutherland LC
    BMC Genomics; 2007 Oct; 8():348. PubMed ID: 17908320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RBM5 inhibits tumorigenesis of gliomas through inhibition of Wnt/β-catenin signaling and induction of apoptosis.
    Jiang Y; Sheng H; Meng L; Yue H; Li B; Zhang A; Dong Y; Liu Y
    World J Surg Oncol; 2017 Jan; 15(1):9. PubMed ID: 28061901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.